TIL Therapy for Patients With Advanced Solid Tumors
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer|Advanced Lung Cancer
Interventions: BIOLOGICAL: Tumor-infiltrating lymphocytes|DRUG: IL-2
Sponsor: NeogenTC